Subacute sclerosing panencephalitis: Difference between revisions
No edit summary |
No edit summary |
||
Line 13: | Line 13: | ||
==[[Subacute sclerosing panencephalitis overview|Overview]]== | ==[[Subacute sclerosing panencephalitis overview|Overview]]== | ||
==[[Subacute sclerosing panencephalitis historical perspective|Historical Perspective]]== | ==[[Subacute sclerosing panencephalitis historical perspective|Historical Perspective]]== | ||
Line 20: | Line 18: | ||
==[[Subacute sclerosing panencephalitis pathophysiology|Pathophysiology]]== | ==[[Subacute sclerosing panencephalitis pathophysiology|Pathophysiology]]== | ||
==[[Subacute sclerosing panencephalitis | ==[[Subacute sclerosing panencephalitis causes|Causes]]== | ||
==[[Subacute sclerosing panencephalitis | ==[[Subacute sclerosing panencephalitis differential diagnosis|Differentiating Subacute sclerosing panencephalitis from other Diseases]]== | ||
==[[Subacute sclerosing panencephalitis | ==[[Subacute sclerosing panencephalitis epidemiology and demographics|Epidemiology and Demographics]]== | ||
==[[Subacute sclerosing panencephalitis | ==[[Subacute sclerosing panencephalitis risk factors|Risk Factors]]== | ||
==[[Subacute sclerosing panencephalitis natural history|Natural History, Complications | ==[[Subacute sclerosing panencephalitis natural history|Natural History, Complications and Prognosis]]== | ||
==Diagnosis== | ==Diagnosis== | ||
[[Subacute sclerosing panencephalitis history and symptoms|History | |||
[[Subacute sclerosing panencephalitis history and symptoms|History and Symptoms]] | [[Subacute sclerosing panencephalitis physical examination|Physical Examination]] | [[Subacute sclerosing panencephalitis laboratory tests|Laboratory Findings]] | [[Subacute sclerosing panencephalitis CT|CT]] | [[Subacute sclerosing panencephalitis MRI|MRI]] |[[Subacute sclerosing panencephalitis other imaging findings|Other Imaging Findings]] | [[Subacute sclerosing panencephalitis other diagnostic studies|Other Diagnostic Studies]] | |||
==Treatment== | ==Treatment== | ||
[[Subacute sclerosing panencephalitis medical therapy|Medical Therapy]] | [[Subacute sclerosing panencephalitis | |||
[[Subacute sclerosing panencephalitis medical therapy|Medical Therapy]] | [[Subacute sclerosing panencephalitis primary prevention|Primary Prevention]] | [[Subacute sclerosing panencephalitis secondary prevention|Secondary Prevention]] | [[Subacute sclerosing panencephalitis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Subacute sclerosing panencephalitis future or investigational therapies|Future or Investigational Therapies]] | |||
==Case Studies== | |||
[[Subacute sclerosing panencephalitis case study one|Case #1]] | |||
{{Viral diseases}} | {{Viral diseases}} |
Revision as of 14:49, 14 December 2012
For patient information, click here
Subacute sclerosing panencephalitis | |
Brain: Subacute Sclerosing Panencephalitis: Micro high mag H&E inflammatory reaction (well depicted). Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology |
Subacute sclerosing panencephalitis Microchapters |
Differentiating Subacute sclerosing panencephalitis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Subacute sclerosing panencephalitis On the Web |
American Roentgen Ray Society Images of Subacute sclerosing panencephalitis |
Directions to Hospitals Treating Subacute sclerosing panencephalitis |
Risk calculators and risk factors for Subacute sclerosing panencephalitis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: SSPE; Dawson disease; Dawson encephalitis; measles encephalitis.
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Subacute sclerosing panencephalitis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | CT | MRI |Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
Template:Skin and subcutaneous tissue symptoms and signs Template:Nervous and musculoskeletal system symptoms and signs Template:Urinary system symptoms and signs Template:Cognition, perception, emotional state and behaviour symptoms and signs Template:Speech and voice symptoms and signs Template:General symptoms and signs
fi:Subakuutti sklerosoiva panenkefaliitti